Autologous Stem Cell Transplantation (DBCOND0035870)

Identifiers

Synonyms

Autologous Stem Cell Transplant / Auto Stem Cell Transplant

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06348147	Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation	Bortezomib Daratumumab Dexamethasone Lenalidomide	treatment	2	not_yet_recruiting
NCT06588413	Olanzapine 2.5 Vs 5 Mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan	Olanzapine	prevention	3	not_yet_recruiting
NCT01164345	Mozobil for Autologous Stem Cell Mobilization	Filgrastim Plerixafor	treatment	2	completed
NCT00976378	NOX-A12 First-in-human (FIH) Study	Olaptesed Pegol	treatment	1	completed
NCT01166009	CIBMTR Research Database	No drug interventions	Not Available	Not Available	recruiting
NCT02981199	Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients	No drug interventions	treatment	Not Available	unknown_status
NCT02006225	Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients.	Plerixafor	treatment	4	unknown_status
NCT05835726	Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.	Daratumumab	Not Available	Not Available	recruiting
NCT03238599	Pedometer Activity Monitoring After ASCT	No drug interventions	other	2	completed
NCT05814718	Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT	Carmustine Cytarabine Etoposide Melphalan Mitoxantrone	treatment	Not Available	not_yet_recruiting
NCT04464434	Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis	No drug interventions	treatment	4	recruiting
NCT06381830	Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma	No drug interventions	treatment	2	recruiting
NCT04920474	Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries	No drug interventions	Not Available	Not Available	recruiting
NCT00396331	AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts	Filgrastim Plerixafor	treatment	2	completed
NCT01895244	Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis	No drug interventions	treatment	2	completed
NCT06377540	MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma	Carmustine Cytarabine Etoposide Melphalan Pembrolizumab	treatment	2	not_yet_recruiting
NCT00291811	Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization	Filgrastim Plerixafor	Not Available	Not Available	approved_for_marketing
NCT01296256	Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).	Bendamustine	treatment	2	completed
NCT02181413	A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant	Ixazomib	treatment	3	completed
NCT05358262	High Heated Humidity in Stem Cell Transplant	No drug interventions	treatment	2	not_yet_recruiting
NCT04653246	Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM	Bortezomib D-mannitol Dexamethasone Isatuximab Lenalidomide	treatment	2	recruiting
NCT04783038	Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients	No drug interventions	supportive_care	Not Available	recruiting
NCT01241708	Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma	Bortezomib Bortezomib D-mannitol Melphalan	treatment	3	completed